Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Interest & Investment Income (2023 - 2025)

Mimedx's Interest & Investment Income history spans 3 years, with the latest figure at $904000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 124.32% year-over-year to $904000.0; the TTM value through Dec 2025 reached $2.9 million, up 391.55%, while the annual FY2025 figure was $2.9 million, 391.55% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $904000.0 at Mimedx, up from $785000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $904000.0 in Q4 2025 and bottomed at -$1.7 million in Q1 2024.
  • The 3-year median for Interest & Investment Income is $340500.0 (2024), against an average of -$138300.0.
  • The largest annual shift saw Interest & Investment Income surged 100.18% in 2024 before it soared 24500.0% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at -$1.7 million in 2023, then surged by 123.99% to $403000.0 in 2024, then soared by 124.32% to $904000.0 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Interest & Investment Income are $904000.0 (Q4 2025), $785000.0 (Q3 2025), and $738000.0 (Q2 2025).